These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36729117)

  • 21. Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022.
    Tenforde MW; Patel MM; Lewis NM; Adams K; Gaglani M; Steingrub JS; Shapiro NI; Duggal A; Prekker ME; Peltan ID; Hager DN; Gong MN; Exline MC; Ginde AA; Mohr NM; Mallow C; Martin ET; Talbot HK; Gibbs KW; Kwon JH; Chappell JD; Halasa N; Lauring AS; Lindsell CJ; Swan SA; Hart KW; Womack KN; Baughman A; Grijalva CG; Self WH;
    Clin Infect Dis; 2023 Mar; 76(6):1030-1037. PubMed ID: 36327388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.
    Melidou A; Broberg E;
    Vaccine; 2017 Sep; 35(37):4828-4835. PubMed ID: 28780977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.
    Flannery B; Clippard J; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Petrie JG; McLean HQ; Belongia EA; Gaglani M; Berman L; Foust A; Sessions W; Thaker SN; Spencer S; Fry AM;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):10-5. PubMed ID: 25590680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
    Flannery B; Zimmerman RK; Gubareva LV; Garten RJ; Chung JR; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Ohmit SE; Belongia EA; McLean HQ; Gaglani M; Piedra PA; Mishin VP; Chesnokov AP; Spencer S; Thaker SN; Barnes JR; Foust A; Sessions W; Xu X; Katz J; Fry AM
    J Infect Dis; 2016 Oct; 214(7):1010-9. PubMed ID: 27190176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria's Sentinel Physician Surveillance Network.
    Redlberger-Fritz M; Kundi M; Popow-Kraupp T
    PLoS One; 2016; 11(3):e0149916. PubMed ID: 26975056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
    Andrew MK; Shinde V; Hatchette T; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney J; McGeer A; Nichols MK; Powis J; Richardson D; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    BMC Infect Dis; 2017 Dec; 17(1):805. PubMed ID: 29284435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
    Skowronski DM; Chambers C; De Serres G; Sabaiduc S; Winter AL; Dickinson JA; Gubbay JB; Fonseca K; Drews SJ; Charest H; Martineau C; Krajden M; Petric M; Bastien N; Li Y; Smith DJ
    J Infect Dis; 2017 Apr; 215(7):1059-1099. PubMed ID: 28180277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
    Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
    Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City.
    Hernández-Hernández VA; Higuera-Iglesias AL; Palma-Cortes G; Tapia-Trejo D; Ávila-Ríos S; González-Fernández RR; Pérez-Moreno LÁ; Zuñiga-Ramos JA; Guadarrama-Pérez C; Sandoval-Gutiérrez JL; Cabello-Gutiérrez C
    Int J Infect Dis; 2022 Dec; 125():114-119. PubMed ID: 36283676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
    Tenforde MW; Weber ZA; DeSilva MB; Stenehjem E; Yang DH; Fireman B; Gaglani M; Kojima N; Irving SA; Rao S; Grannis SJ; Naleway AL; Kirshner L; Kharbanda AB; Dascomb K; Lewis N; Dalton AF; Ball SW; Natarajan K; Ong TC; Hartmann E; Embi PJ; McEvoy CE; Grisel N; Zerbo O; Dunne MM; Arndorfer J; Goddard K; Dickerson M; Patel P; Timbol J; Griggs EP; Hansen J; Thompson MG; Flannery B; Klein NP
    J Infect Dis; 2023 Jul; 228(2):185-195. PubMed ID: 36683410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
    Noh JY; Lim S; Song JY; Choi WS; Jeong HW; Heo JY; Lee J; Seo YB; Lee JS; Wie SH; Kim YK; Park KH; Jung SI; Kim SW; Lee SH; Lee HS; Yoon YH; Cheong HJ; Kim WJ
    PLoS One; 2017; 12(5):e0178010. PubMed ID: 28542417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.
    Sominina A; Danilenko D; Komissarov AB; Pisareva M; Fadeev A; Konovalova N; Eropkin M; Petrova P; Zheltukhina A; Musaeva T; Eder V; Ivanova A; Komissarova K; Stolyarov K; Karpova L; Smorodintseva E; Dorosh A; Krivitskaya V; Kuznetzova E; Majorova V; Petrova E; Boyarintseva A; Ksenafontov A; Shtro A; Nikolaeva J; Bakaev M; Burtseva E; Lioznov D
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
    Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
    Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.
    Korsun N; Daniels R; Angelova S; Ermetal B; Grigorova I; Voleva S; Trifonova I; Kurchatova A; McCauley J
    J Med Microbiol; 2020 Jul; 69(7):986-998. PubMed ID: 32459617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.